GlaxoSmithKline-Vir COVID-19 Antibody Drug Granted EUA In U.S.

The U.S. Food and Drug Administration has granted an emergency use authorization for a COVID-19 antibody drug Sotrovimab made by GlaxoSmithKline (GSK, GSK.L) and Vir Biotechnology. Sotrovimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy.

from RTT - Top Story https://ift.tt/3vuhx71
via IFTTT